15 April 2025
Top hires for VC & PE portfolio companies Q1-2025
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
Function | Focus area | Location |
---|---|---|
CEO | Exosome technologies | Italy |
CEO | CRO | France |
CEO | Cell & gene therapy tools | UK |
Chief Development Officer | Cell reprogramming | Sweden |
Chief Financial Officer | Antibody-drug conjugates | Germany/ US |
Chief Business Officer | Small molecule therapeutics | Switzerland/ US |
Chief Scientific Officer | AI platform technologies | UK |
Chief Commercial Officer | CDMO | UK |
Chief Technology & Operations Officer | Precision fermentation | Sweden |
Chief R&D Officer | Mitochondrial medicine | UK |
VP, Head of Biometrics | Oncology drug development | US |
VP, CMC & Development | T-cell technologies | UK |
Head of Regulatory | Small molecule inhibitors | US |
Global Marketing Director Biosurgery | Surgical technologies | US |
General Manager France | Remote patient monitoring | UK/ France |
Head of Hospitals & Value Access | Ophthalmology therapeutics | Italy |
Senior Executive Director, Translational | Radiopharmaceuticals | US |
Senior Director, New Ventures and Investments | University incubator/ accelerator | Australia |
Newly opened projects include:
Function | Focus area | Location |
---|---|---|
CEO | Bio-storage solutions | UK |
Chief Financial Officer | Cardiac devices | France |
Chief Scientific Officer | tRNA platform | US |
Chief Operating Officer | Medical devices | UK |
Chief Business Officer | AI-enabled imaging | Spain |
Chief Scientific Officer | Neuropsychiatry | US |
Head of Sales and Marketing | Specialty pharma | UK |
Country CEO | Healthcare services | France |
International Commercial Director | Specialty pharma | UK |
Board Director | Oncology pharma | Australia |
Board Director | Antibody platform | Canada |
Chair | Healthtech | Belgium |
Fund Managing Partner | Life sciences research institution | UK |
Related
-
Events
Bio€quity Europe 2025
12 May 2025 – 14 May 2025
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023